Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.
Bloem, Bastiaan R
Ypinga, Jan HL
Canning, Colleen G
De Vries, Nienke M
J Parkinsons Dis
MetadataShow full item record
Bloem, B. R., Ypinga, J. H., Willis, A., Canning, C. G., Barker, R., Munneke, M., & De Vries, N. M. (2018). Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.. J Parkinsons Dis, 8 (1), 45-58. https://doi.org/10.3233/JPD-171277
The scientific evidence to support the value of a range of non-pharmacological interventions for people with Parkinson's disease (PD) is increasing. However, showing unequivocally that specific interventions are better than usual care is not straightforward because of generic drawbacks of clinical trials. Here, we address these challenges, specifically related to the context of evaluating complex non-pharmacological interventions for people with PD. Moreover, we discuss the potential merits of undertaking "real world" analyses using medical claims data. We illustrate this approach by discussing an interesting recent publication in The Lancet Neurology, which used such an approach to demonstrate the value of specialized physiotherapy for PD patients, over and above usual care physiotherapy.
Humans, Parkinson Disease, Treatment Outcome, Follow-Up Studies, Forecasting, Quality of Life, Cost-Benefit Analysis, Cost Savings, Insurance Claim Review, Netherlands, Physical Therapy Modalities, Randomized Controlled Trials as Topic
Professor Bastiaan R. Bloem is supported by a research grant of the Parkinson’s Foundation. Dr. Nienke M. de Vries is supported by a research grant from The Netherlands Organization for Health Research and Development. Dr. Allison Willis is supported by the Parkinson’s Foundation, the National Institutes of Health (R01-NS-099129-01A1), the Patient Centred Outcomes Research Institute, and the University of Pennsylvania.
External DOI: https://doi.org/10.3233/JPD-171277
This record's URL: https://www.repository.cam.ac.uk/handle/1810/273276